KRAS and colorectal carcinoma: Furthermore, another study indicated that AKT and Wnt pathways were slightly attenuated by the k-Ras inhibitors ABT263 and axitinib in k-Ras mutant CRC cells [148], which further suggested that Ras signaling could interact with AKT and Wnt pathways in CRC.